FALLS CHURCH, Va., Jan. 9, 2019 /PRNewswire-PRWeb/ -- Building a World-Class Drug Supply Chain Tips for Compliance and
The "ultimate" supply chain regulatory deadline of 2023 may be five years away, but now is the time for all industry stakeholders, manufacturers, wholesalers, distributors and dispensers, to take a step back and plan for the next five years.
It's time to begin laying the foundation of a digital supply chain with track-and-trace capabilities at the center of the systems and processes.
2019 will be a critical year for industry collaboration and knowledge sharing. Track-and-trace expert Evren Ozkaya, founder and CEO of Supply Chain Wizard, LLC, will help manage the supply chain efficiently, while remaining in regulatory compliance.
Over the course of 90 minutes he'll cover:
It's time to focus on the challenges and opportunities to minimize regulatory risks and maximize business value the next five years.
Meet The Presenter: Evren Ozkaya, Ph.D. Evren Ozkaya is the Founder & CEO of Supply Chain Wizard, LLC (an Inc. 5000 and NJ Fast 50 Honoree in 2018), a global management consulting & digital solutions firm helping clients establish and execute cost-effective and scalable regulatory compliance and digital transformation programs via data-driven decision making by leveraging the state-of-the-art technology. `
Who Will Benefit:
Webinar Details: Building a World-Class Drug Supply Chain Tips for Compliance and Digital Transformation **An FDAnews Webinar** Friday, Jan. 18, 2019, 1:30 p.m. - 3:00 p.m. EST http://www.fdanews.com/drugsupplychain
Tuition: $287 per site
Easy Ways to Register: Online: http://www.fdanews.com/drugsupplychain By phone: 888-838-5578 or 703-538-7600
About FDAnews: FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.
Subscribe to our Free Newsletters!